Journée d'étude TDI _ Diagnostic Etiologique _ Dr Marie-Thérèse ABI-WARDE et Dr Salima EL CHEHADEH

Value of the Information & Strength of the Argument

The presentation provides valuable insights into the practical impact of etiological diagnosis in intellectual disability. The speakers effectively argue that identifying a specific genetic or metabolic cause can significantly alter patient management, from ending diagnostic odysseys and providing psychological relief to enabling precise genetic counseling and guiding treatment decisions. They support their arguments with concrete clinical cases, such as the Kleefstra syndrome case and the EIF3F mutation case, which illustrate the real-world benefits. The discussion of metabolic diseases highlights the importance of early diagnosis for conditions where treatment can modify the disease course. The argumentation is coherent and grounded in clinical experience, though it relies on anecdotal evidence rather than systematic data.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is generally high, as the speakers are specialists and the content aligns with current medical knowledge. They mention specific syndromes, genes, and a national study (DéfiDIA) without providing formal citations. The quality of sources is not explicitly documented, but the information appears reliable. The title accurately reflects the content, which is a focused discussion on etiological diagnosis and its impact. No comments were provided for analysis.

The title accurately reflects the content, which focuses on the etiological diagnosis of intellectual disability and its impact on management.

8/10

The presentation is given by two medical doctors (a clinical geneticist and a neuropediatrician) and is based on clinical experience and current scientific knowledge. They cite specific genetic syndromes, studies (e.g., DéfiDIA), and diagnostic techniques. However, no formal citations or references are provided in the video description, and the content is largely anecdotal and based on expert opinion rather than a systematic review.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction by Dr. Abi-Warde on the importance of temporal context in etiological diagnosis.
• 02:00Dr. El Chehadeh begins overview of etiologies of TDI, including genetic, environmental, and metabolic causes.
• 05:00Explanation of genetic causes: chromosomal anomalies, microdeletions, and point mutations.
• 08:00Discussion of the rapid progress in gene discovery and the fact that 50% of cases remain undiagnosed.
• 10:00Clinical case of Kleefstra syndrome (HMT1 mutation) illustrating the impact of naming the disease.
• 13:00Case of MECP2 duplication syndrome with a carrier mother, highlighting genetic counseling implications.
• 16:00Case solved by whole genome sequencing (EIF3F mutation) and its impact on prenatal diagnosis.
• 19:00Transition to neuropediatric causes, focusing on metabolic diseases and red flags.
• 22:00Case of a child with a lysosomal storage disease (MPS) where early treatment can improve outcomes.
• 25:00Conclusion summarizing the impact of etiological diagnosis on management and prognosis.

• DéfiDIA study — National study offering whole genome sequencing to patients with intellectual disability without diagnosis.

• DéfiDIA study — The study is mentioned as a national initiative for whole genome sequencing in undiagnosed intellectual disability.